Inventor · disambiguated record
Pierre Deprez
Also filed as: DEPREZ PIERRE · DEPREZ PIERRE MARC MARIE JOSEPH
17 granted patents·6 pending applications·106 citations·filing 1995–2021
92Inventor score
Files withGALAPAGOS NV7DEPREZ PIERRE4HOECHST MARION ROUSSEL INC3ROUSSEL UCLAF2AKASHI THERAPEUTICS INC1
Top patents by PatentIndex Score
23 records- 0190US9926281B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2015·Granted Mar 27, 2018·6 cites·18 claims
- 0288US10487060B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2018·Granted Nov 26, 2019·4 cites·28 claims
- 0388US7605261B2Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel useAMGEN INC·Filed 2006·Granted Oct 20, 2009·12 cites·23 claims
- 0482US8247412B2Urea derivatives methods for their manufacture and uses thereofDEPREZ PIERRE·Filed 2006·Granted Aug 21, 2012·11 cites·33 claims
- 0577US8324396B2Derivatives of urea and related diamines, methods for their manufacture, and uses thereforDEPREZ PIERRE·Filed 2008·Granted Dec 4, 2012·5 cites·6 claims
- 0674US7875609B2Urea derivatives, processes for their preparation, their use as medicaments, and pharmaceutical compositions containing themGALAPAGOS SASU·Filed 2006·Granted Jan 25, 2011·4 cites·60 claims
- 0773US7968581B2Imidazolidine compounds as androgen receptor modulatorsGALAPAGOS NV·Filed 2009·Granted Jun 28, 2011·2 cites·57 claims
- 0869US11718588B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2021·Granted Aug 8, 2023·0 cites·16 claims
- 0968US10941117B25-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2019·Granted Mar 9, 2021·0 cites·4 claims
- 1066US5811445AMethod of preventing abnormal stimulation of AT1 and AT2 receptorsROUSSEL UCLAF·Filed 1995·Granted Sep 22, 1998·20 cites·4 claims
- 1162US5807878ATetrasubstituted imidazolesROUSSEL UCLAF·Filed 1995·Granted Sep 15, 1998·20 cites·9 claims
- 1261US5977155AImidazole-5-carboxamidesHOECHST MARION ROUSSEL INC·Filed 1998·Granted Nov 2, 1999·14 cites·5 claims
- 1348US2016250188A1Methods for treatment of muscular dystrophiesBUSH ERNEST D·Filed 2014·Application pending·0 cites
- 1447US6136842ASulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivativesHOECHST MARION ROUSSEL INC·Filed 1997·Granted Oct 24, 2000·7 cites·8 claims
- 1547US2002161030A1Sulpur derivatives containing a retroamide bond as inhibitors of endothelin-converting enzymesHOECHST MARION ROUSSEL INC·Filed 2002·Application pending·0 cites
- 1646US2004053925A1Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel useFiled 2002·Application pending·0 cites
- 1746US2019167640A1Methods for treatment of muscular dystrophiesAKASHI THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1845US2008125424A1Derivatives of urea and related diamines, methods for their manufacture, and uses thereforDEPREZ PIERRE·Filed 2007·Application pending·0 cites
- 1943US2012283255A1Urea derivatives, methods for their manufacture, and uses thereforDEPREZ PIERRE·Filed 2012·Application pending·0 cites
- 2038US10829478B25-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Nov 10, 2020·0 cites·37 claims
- 2137US10550100B25-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Feb 4, 2020·0 cites·15 claims
- 2237US8383608B2Imidazolidine compounds as androgen receptor modulatorsDART THERAPEUTICS LLC·Filed 2011·Granted Feb 26, 2013·0 cites·56 claims
- 2335US6420341B1Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitorsAVENTIS PHARMA SA·Filed 1997·Granted Jul 16, 2002·1 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →